BioCardia, Inc. (BCDA)
NASDAQ
BioCardia, Inc. EBITDA 2010–2025
BioCardia, Inc. annual/quarterly ebitda history and growth rate from 2010 to 2025. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- BioCardia, Inc. ebitda for the quarter ending March 31, 2025 was -2.7 M, a 20.30% increase year-over-year.
- BioCardia, Inc. ebitda for the twelve months ending March 31, 2025 was -11.8 M, a 20.52% decrease year-over-year.
- BioCardia, Inc. annual ebitda for 2025 was -8.3 M, a 4.03% increase from 2024.
- BioCardia, Inc. annual ebitda for 2024 was -7.9 M, a 31.37% decrease from 2023.
- BioCardia, Inc. annual ebitda for 2023 was -11.6 M, a 2.19% decrease from 2022.
- BioCardia, Inc. annual ebitda for 2022 was -11.8 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
BioCardia, Inc. EBITDA — FAQ
BioCardia, Inc. (BCDA) ebitda over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BCDA's ebitda history?
The chart and table above show BioCardia, Inc.'s ebitda by year and by quarter, including the growth rate.